Curated News
By: NewsRamp Editorial Staff
September 25, 2026

SS Innovations Launches Robotic Cardiac Surgery Program in India

Discuss on SubstackView history of this news story on GitHub
Original Source

TLDR

  • SS Innovations installed 238 SSi Mantra systems across 12 countries, up 42 percent since 2025, strengthening its robotic surgery market position.
  • The SSi Mantra robotic system enabled a LIMA take-down at HCG Hospital in Ahmedabad, expanding robotic cardiac surgery capabilities.
  • Robotic cardiac surgery programs like HCG Hospital's can improve patient outcomes and expand access to advanced care in India.
  • SS Innovations is pursuing FDA review and EU CE marking for its SSi Mantra system while expanding into Colombia, Sri Lanka, and the Philippines.

Impact - Why it Matters

This news matters because it highlights the ongoing global adoption of robotic-assisted surgery, which can lead to less invasive procedures, reduced recovery times, and improved patient outcomes. The expansion of SS Innovations into new international markets, coupled with its pursuit of FDA and CE mark approvals, signals increasing competition and innovation in the surgical robotics field. As more hospitals adopt systems like the SSi Mantra, patients worldwide may gain access to advanced surgical care, while investors should note the company’s rapid installation growth and regulatory progress as indicators of its market potential.

Summary

SS Innovations International (NASDAQ: SSII), a developer of advanced surgical robotic technologies, has expanded the clinical reach of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital in Ahmedabad, India. The program commenced with a robotic left internal mammary artery (LIMA) take-down, performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra 3.0 system. This milestone procedure was supported by the SS Innovations team and marks a significant step in advancing robotic cardiac surgery in the region. The company celebrated the achievement in a LinkedIn post, congratulating the surgical team and reaffirming its commitment to enabling hospitals with innovative robotic solutions. This launch follows SS Innovations’ recent expansion into Colombia, Sri Lanka, and the Philippines, bringing the total number of SSi Mantra systems installed to 238 as of September 8, a 42% increase from the end of 2025. The system is now installed across 12 countries, underscoring the company’s growing global footprint. As part of its ongoing growth strategy, SS Innovations is actively pursuing U.S. FDA review and European Union CE marking to further expand into additional international markets. For more details, readers can Read More and stay updated via the company’s newsroom at https://ibn.fm/SSII.

Source Statement

This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations Launches Robotic Cardiac Surgery Program in India

Blockchain registration record for this content